(Date:12/2/2009)...EBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed that the U.S. Food and Drug Administration (FDA...ny,s PI3K/Akt pathway inhibitor compound, perifosi...ctory multiple myeloma. Keryx Biopharmaceuticals, ...
(Date:12/1/2009)...LINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall/ ...y announced revenue guidance for the fourth quarte...lion, as compared with $69 million for the fourth ...esults was the first of two installment payments o...urth quarter 2008 results was a one-time $1.8 mill...
(Date:12/1/2009)..., CAMBRIDGE, Mass., Dec. 1 To a...stry and to promote its potential, a group of indi...he Synthetic Biology Industry Association (SynBIA)...f the association is to provide a forum for indivi...industry, address its opportunities and its challe...
(Date:12/1/2009)...N FRANCISCO, Dec. 1 The Burrill Bi...f the value it lost in October. The Select,s gain ... month for the general markets with the Dow up 6.5...he gains held firm in the final two trading days o...h Thanksgiving holiday shopping and Dubai,s report...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4(Date:12/2/2009)...s of carbon about a nanometer in diameterhave been...ultrastrong fibers, electrical wires in molecular ...ells. Thanks to a new development by researchers a...gy (NIST) and five partners, you can add one more ... of an aggressive form of breast cancer. , HER2 ...
(Date:12/2/2009)...cording to the National Institute of Health, 40 pe...abetes already have some stage of diabetic retinop...caused by leaky blood vessels, is a major cause of...he most feared diabetic complications. In fact, u...s for 10 years or more will experience some form o...
(Date:12/1/2009)...Dec. 1 GestureTek Inc. today annou...ey, portable, plug and play interactive projection...inment and touring promotions. GestureTek is the i...enabled gesture recognition technology for interac...ms. ,, Guaranteed for quality, the CUBE has TUV...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 1Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 3Regeneron Announces September 2009 Investment Conference Presentations 56871 1Regeneron Announces September 2009 Investment Conference Presentations 56871 2BayCare Outpatient Center Opens in Westchase Florida 56869 1GIBCO Schneider's Drosophila Medium (1X) liquid from Invitrogen
Virology LabFax from Promega
GIBCO IPL-41 Insect Medium (1X) liquid from Invitrogen
GIBCO Newborn Calf Serum from Invitrogen
Biology Products: